We take a look at the criteria and considerations that healthcare providers and patients should weigh when contemplating GLP-1 therapy
Treating Mitochondrial Dysfunction: A Layered Strategy Treatment depends on whether the problem is a primary mitochondrial disease, acquired dysfunction or one component of a broader psychiatric, neurological or metabolic illness
It triggers the release of growth hormone without significantly impacting other hormones such as cortisol or prolactin, which minimizes side effects
Both in vivo and in vitro studies provide substantial evidence of the neuroprotective benefits of GLP-1RAs through the modulation of inflammation, mitochondrial function, ROS, tau hyperphosphorylation, and anti-apoptotic pathways
Outside of writing about sleep, she is a bestselling author, improviser, and creative writing teacher based out of Austin